This inventor holds 1 USPTO granted patent. Top assignee: The University of New Mexico. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Hiroshi Ide: Innovator in Cancer Treatment
Introduction
Hiroshi Ide is a notable inventor based in Higashihiroshima, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on enhancing the efficacy of cancer therapies, particularly in overcoming resistance to conventional treatments.
Latest Patents
Hiroshi Ide holds a patent titled "Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells." This patent describes a method for treating subjects suffering from neoplasms, including radiotherapeutic-resistant cancers. The invention involves administering a therapeutically effective amount of 5-formyl-2'-deoxyuridine or its derivatives, in combination with 5-fluorouracil or its prodrugs. This innovative approach aims to improve treatment outcomes for patients with colorectal cancer and metastatic colorectal cancer.
Career Highlights
Hiroshi Ide is affiliated with the University of New Mexico, where he continues to advance his research in cancer therapies. His dedication to improving patient care through scientific innovation is evident in his work and contributions to the medical community.
Collaborations
Hiroshi Ide has collaborated with esteemed colleagues, including Alan Edward Tomkinson and Yoshihiro Matsumoto. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatments.
Conclusion
Hiroshi Ide's innovative work in cancer treatment exemplifies the impact of research and patents in advancing medical science. His contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in healthcare.